For inquiries regarding establishing pharmaceutical manufacturing facilities in Kinshasa or abroad, please contact us at.

With extensive experience in manufacturing various pharmaceutical products, including those essential for government tenders in hospitals, Kinshasa covers five categories of plants. This enables us to produce a diverse range of drug dosage forms such as generics, beta-lactams, cephalosporins, cytotoxic hormones, and biologicals. Furthermore, our specialization extends to the production of dextrose IV fluids, human albumin, IVIG injections, erythropoietin, MABS plants, insulin, and other fungal, E. coli, and mammalian-based products.

Our range of drug dosage forms includes tablets, capsules, liquid orals, creams, ointments, and suppositories for oral solid and semi-solid dosages. For injectables, we provide solution injections in ampoules and vials, eye drops, sterile powder for injection, and lyophilized injections, encompassing liposomal, PEGylation, and nanoparticles. Additionally, we offer implants such as goserelin acetate.

Local production of liquid orals offers significant advantages, including reduced transportation costs and time savings. Moreover, construction materials and contractors are readily available in every country, as are packing components. In today’s interconnected world, economical bulk drugs are accessible worldwide, facilitating the establishment of manufacturing units in different countries to meet local requirements and leverage incentives for employment generation.

Our manufacturing units, featuring plasma plants for human albumin and IVIG production, IV fluid plants, liquid oral plants, and other value-adding facilities, are available for installation at your preferred location. We specialize in facilitating pharmaceutical technology transfer, ensuring seamless knowledge transfer from development to commercial production or between manufacturing sites, mergers, acquisitions, or transitions to contract manufacturers.